Neoadjuvant entrectinib for NTRK fusion-positive rectal gastrointestinal stromal tumor achieving partial response and sp...
Case Report
Neoadjuvant entrectinib for NTRK fusion-positive rectal gastrointestinal stromal tumor achieving partial response and sphincter preservation: a case report and literature review